We are live on
!
Find out more
PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$3.38B
1-Year Est. Return
14.09%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+14.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.93B
AUM Growth
+$650M
(+28%)
Cap. Flow
+$595M
Cap. Flow
% of AUM
20.29%
Top 10 Holdings %
Top 10 Hldgs %
12.64%
Holding
2,402
New
555
Increased
562
Reduced
449
Closed
831
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$118M |
| 2 |
Cigna
CI
|
+$29.5M |
| 3 |
Lowe's Companies
LOW
|
+$25.4M |
| 4 |
NVIDIA
NVDA
|
+$24.8M |
| 5 |
Visa
V
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.2M |
| 2 |
American International
AIG
|
+$14.2M |
| 3 |
Merck
MRK
|
+$13.6M |
| 4 |
Booking.com
BKNG
|
+$13M |
| 5 |
Zoetis
ZTS
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11% |
| 2 | Healthcare | 8.44% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Financials | 7.12% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Oric Pharmaceuticals
ORIC
$1.42B
| $32.6K | ﹤0.01% |
+5,713
| New | +$29.9K |
|
1352
OceanFirst Financial
OCFC
$1.88B
| $31.8K | ﹤0.01% |
+1,723
| New | +$38.2K |
|
1353
Revolve Group
RVLV
$1.72B
| $31.7K | ﹤0.01% |
1,207
-114,211
| -99% | -$2.95M |
|
1354
Americold
COLD
$4.32B
| $31.4K | ﹤0.01% |
+1,105
| New | +$33K |
|
1355
Employers Holdings
EIG
$871M
| $31.3K | ﹤0.01% |
750
+325
| +76% | +$13.9K |
|
1356
The RMR Group
RMR
$346M
| $31.2K | ﹤0.01% |
+1,188
| New | +$33.3K |
|
|
AD
1357
Array Digital Infrastructure
AD
$3.09B
| $31K | ﹤0.01% |
+1,496
| New | +$33.5K |
|
1358
Cabaletta Bio
CABA
$442M
| $30.9K | ﹤0.01% |
+3,742
| New | +$35K |
|
|
HTBK
1359
DELISTED
Heritage Commerce
HTBK
| $30.8K | ﹤0.01% |
+3,698
| New | +$42.3K |
|
1360
Evolution Petroleum
EPM
$135M
| $30.7K | ﹤0.01% |
+4,859
| New | +$31.1K |
|
1361
C4 Therapeutics
CCCC
$502M
| $30.5K | ﹤0.01% |
9,703
+7,787
| +406% | +$45.8K |
|
1362
PUT
Citizens Financial Group
CFG
$31.2B
| $30.4K | ﹤0.01% |
+1,000
| New | +$39.2K |
|
1363
Ponce Financial Group
PDLB
$501M
| $30.2K | ﹤0.01% |
+3,850
| New | +$34.9K |
|
1364
Stoneridge
SRI
$201M
| $29.9K | ﹤0.01% |
+1,601
| New | +$34.4K |
|
1365
ClearPoint Neuro
CLPT
$470M
| $29.9K | ﹤0.01% |
+3,547
| New | +$31.1K |
|
|
IBTX
1366
DELISTED
Independent Bank Group, Inc.
IBTX
| $29.9K | ﹤0.01% |
645
-252
| -28% | -$14.3K |
|
1367
Rayonier Advanced Materials
RYAM
$570M
| $29.8K | ﹤0.01% |
+4,758
| New | +$33.2K |
|
1368
Monarch Casino & Resort
MCRI
$2.2B
| $29.7K | ﹤0.01% |
+401
| New | +$30.5K |
|
1369
Gray Television
GTN
$520M
| $29.7K | ﹤0.01% |
3,401
-16,741
| -83% | -$187K |
|
1370
Savara
SVRA
$1.08B
| $29.2K | ﹤0.01% |
+14,981
| New | +$33.8K |
|
1371
Star Holdings Shares of Beneficial Interest
STHO
$117M
| $29K | ﹤0.01% |
+1,667
| New | +$32.4K |
|
1372
Baxter International
BAX
$14B
| $28.6K | ﹤0.01% |
705
-58,781
| -99% | -$2.49M |
|
1373
Silicon Laboratories
SLAB
$7.28B
| $28.5K | ﹤0.01% |
163
-2,582
| -94% | -$434K |
|
|
NXDT
1374
NexPoint Diversified Real Estate Trust
NXDT
$261M
| $28.2K | ﹤0.01% |
+2,721
| New | +$32.2K |
|
1375
ImmunityBio
IBRX
$8.11B
| $28.2K | ﹤0.01% |
+15,503
| New | +$48.2K |
|
Similar funds
CC
SS
GW
WMSA
GC
WP
BWM
DI
Point72 Middle East FZE's Q1 2023 Portfolio in Review
As of Q1 2023, Point72 Middle East FZE held 2,402 positions worth $2.93B, up 28% from $2.28B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Point72 Middle East FZE deployed $595M of net new capital in Q1 2023, opening 555 new positions and adding to 562 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 295,544 shares worth $121M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Merck, an estimated $13.6M trimmed.
- Point72 Middle East FZE's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 295,544 shares worth $121M.
- Point72 Middle East FZE added most to NVIDIA in Q1 2023, an estimated $24.8M increase.
- Point72 Middle East FZE's biggest Q1 2023 reduction was Merck, cutting an estimated $13.6M.
- Point72 Middle East FZE fully exited Advanced Micro Devices in Q1 2023, selling an estimated $19.2M.
- Point72 Middle East FZE's ten largest holdings make up 13% of its $2.93B portfolio in Q1 2023.
- Point72 Middle East FZE opened 555 new positions and closed 831 in Q1 2023.
- Point72 Middle East FZE's portfolio value rose 28% quarter-over-quarter to $2.93B.
Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.